|Printable version||E-mail this to a friend|
Commission reports on Progress in the Development of Alternative Methods to Animal Testing for Cosmetics
The European Commission presented yesterday its yearly report on Alternative Methods to Animal Tests in the Field of Cosmetics to the European Parliament and Council. The Cosmetics Directive1 prohibits animal testing in the EU of finished cosmetic products since 2004, animal testing of ingredients of cosmetic products is prohibited since 2009. A marketing ban is also in place which prohibits selling in the EU cosmetic products containing ingredients which have been tested on animals irrespective of the place of the testing after March 2009. For many of the tests needed to ensure the safety of cosmetic products alternative methods are developed and validated by now. However, work continues to close the remaining gap for the small number of the most complex effects2 on health for which the marketing ban deadline comes into force in March 2013.
The report published yesterday stresses the continued commitment in Europe and worldwide to find alternative approaches. Despite this commitment and progress in research finding alternative methods for testing these remaining complex endpoints will not be possible by the 2013 deadline according to the Commission's report. The report is based on the findings of scientific experts who have been assessing the availability of alternative methods and prospects for the future. While full replacement is not possible, there is potential for partial replacement strategies and developing a 'toolbox' of test methods to be improved until the goal can be reached. The lack of full alternatives does not mean that the Commission will propose postponing the deadline. Instead. the Commission is currently assessing the impact of the entry into force of the ban in 2013 without alternatives and will decide on next steps on the basis of the full impact assessment.
Health and Consumer Commissioner, John Dalli said "Over the last 20 years more than 200 million euros has been dedicated to research in this area in the EU and the commitment to finding alternatives to animal testing continues both in Europe and worldwide. This research and development has not only reduced the number of animals used in testing, it is at the same time yielding important results in terms of better science to the benefit of consumer safety."
What efforts have been made to find alternatives?
Considerable amounts of funding have been spent to find and validate new alternative tests. Over the last 20 years the EU contribution to research on alternatives amounts to some 200 million Euro; under the 7th Framework Programme more than 65 million Euro have been so far committed to the funding of alternative methods.
The Commission's Joint Research Centre is putting a lot of efforts into the validation of alternative methods, through its Centre for the Validation of Alternative Methods (ECVAM), hosted by the JRC's Institute for Health and Consumer Protection. Moreover, in order to promote synergies between different sectors concerning the development of alternative methods, the European Partnership for Alternative Approaches to Animal Testing (EPAA) was created in 2005. It is a joint initiative of the European Commission, industry and trade federations. The Partnership’s work focuses on mapping existing research, developing new alternative approaches and strategies, and promoting communication, education, validation and acceptance of alternative approaches.
At international level, the Commission promotes intensified cooperation to facilitate the development and the validation of alternative methods and their recognition by our main partners. A framework of cooperation has been established between the US, Japan and Canada, in a regulatory dialogue called "International Cooperation on Cosmetic Regulation" (ICCR), which led to the International Cooperation on Alternative Test Methods (ICATM).
What progress has been made?
Validated alternative methods are available for the identification of corrosive substances, skin irritants and severe eye irritants, skin phototoxicity and skin penetration as well as to assess genotoxicity. Significant advances have been made in reducing the number of animals used in tests, for example in relation to acute toxicity.
In relation to the complex endpoints of repeated-dose toxicity (including skin sensitisation and carcinogenicity), reproductive toxicity and toxicokinetics, the understanding of toxicological processes in the human body has improved significantly over the last decade and continues to do so at an accelerating rate. Advanced methods and approaches hold a lot of promise for the future development of more predictive risk assessment, based on improved understanding of how toxic substances reach the target cells/organs (toxicokinetics) and perturb critical biological pathways. Many alternative methods are under development and there is potential for partial replacement strategies.
What next ?
The European Commission is currently assessing the impacts of the implementation of the full marketing ban by 2013 (environmental, animal welfare, economic and social) and on the basis of that assessment will decide whether or not to make a proposal in relation to the marketing ban. The Commission will announce its final decision by the end of 2011.
Latest News from
EU values must be respected in Hungary and in all other member states, MEPs say23/10/2014 10:05:31
Concerns about perceived threats to democracy, the rule of law and fundamental rights in Hungary were raised by MEPs in a debate with the Italian Presidency of the Council, represented by Benedetto Della Vedova, and Commissioner Martine Reicherts on Tuesday.
Commission adopts detailed rules on contributions of banks to resolution funds23/10/2014 09:10:53
The European Commission has recently adopted a delegated act and a draft proposal for a Council implementing act to calculate the contributions of banks to the national resolution funds and to the Single Resolution Fund respectively.
Antitrust: Commission settles RBS-JPMorgan cartel in derivatives based on Swiss franc LIBOR; imposes € 61.6 million fine on JPMorgan22/10/2014 16:20:38
The European Commission has found that two international banks, RBS and JP Morgan, participated in an illegal bilateral cartel aimed at influencing the Swiss franc Libor benchmark interest rate between March 2008 and July 2009.
Antitrust: Commission sends Statement of Objections to Honeywell and DuPont regarding cooperation on new refrigerant used in car air conditioning systems22/10/2014 15:05:19
The European Commission has informed Honeywell International Inc. (Honeywell) and E.I. du Pont de Nemours and Company (DuPont) of its preliminary view that the cooperation they entered into in 2010, based on several agreements on the production of a new refrigerant for use in car air-conditioning systems (R-1234yf), may have limited its availability and technical development, in breach of EU antitrust rules. The sending of a statement of objections does not prejudge the final outcome of the investigation.